Antithyroid Drugs

Research output: Contribution to journalReview articlepeer-review

Abstract

THE modern era of antithyroid-drug therapy began in 1941 with the chance observations of two groups working independently in Baltimore, Maryland. J. B. MacKenzie and colleagues, studying the antibiotic effects of sulfaguanidine on the intestinal flora of rats, noted thyroid hyperplasia in all animals exposed to this drug.1 At the same time, Richter and Clisby, studying taste preferences, observed goiters in rats fed the very bitter compound phenylthiocarbamide.2 MacKenzie3 and Astwood4 and their colleagues simultaneously reported that the goitrogenic activity of these compounds was due to the inhibition of thyroid hormone biosynthesis, and that the active principle in both drugs.

Original languageEnglish (US)
Pages (from-to)1353-1362
Number of pages10
JournalNew England Journal of Medicine
Volume311
Issue number21
DOIs
StatePublished - Nov 22 1984
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Antithyroid Drugs'. Together they form a unique fingerprint.

Cite this